Overview
Participants will complete questionnaires before surgery, between 2 to 4 weeks after surgery, and 6 months after surgery.
Eligibility
Inclusion Criteria:
- Age ≥18 years
- Clinical stage I tumor (AJCC 8th edition) suitable for segmentectomy, according to the treating thoracic surgeon
- Pathology of NSCLC
- Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology.
- Patients must undergo segmentectomy for a peripheral lesion ≤2 cm to be included in
the primary analysis. Individual ligation of the segmental artery(s) and segmental bronchus is the minimum definition for a segmentectomy. Division of the segmental vein and intraoperative frozen section to assess surgical margins and N1 lymph nodes are strongly encouraged, but the absence of either is not a criterion for exclusion.
Other considerations:
- Patients with ground-glass opacities will have their tumor size recorded on the basis of the size of the solid component.
- Any non-lung cancer treated in the past with no obvious recurrence or ongoing treatment is not a criterion for exclusion.
- The registry study will be monitored by Thoracic Surgery team at MSK.
- This study will be in collaboration with the Thoracic Surgical Oncology Group (TSOG) of the American Association for Thoracic Surgery.
Exclusion Criteria:
- Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years
- History of chemotherapy or radiation therapy for a previous lung cancer
- Synchronous secondary cancer in the lung or elsewhere in the body at the time of surgery
- Carcinoid tumors
- History of other malignancies within the past 3 years, with the exception of non-melanoma skin cancer, superficial bladder cancer, and carcinoma in situ of the cervix
- Actively receiving treatment for other malignancies
- Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥2
segmentectomies from different lobes either en bloc or separate will be excluded from
the primary analysis.
- Multi-segmental resection from the same lobe is not a criterion for exclusion.